At the news
? BEARISHIMPACT 6/10 424B5 filed Mar 27, 2026 at 17:13 ET
Q32 Bio Inc. (QTTB) has filed a 424B5 prospectus supplement to register the at-the-market offering of up to $14.2 million in common stock through Cantor Fitzgerald. The offering allows the company to sell shares from time to time at prevailing market prices, with Cantor earning a 3% commission on sales. The company intends to use the proceeds for working capital and advancing its lead drug candidate, bempikibart, into future clinical trials for alopecia areata.
- Q32 Bio is offering up to $14,200,000 in common stock through an at-the-market offering via Cantor Fitzgerald
- The offering has no minimum amount and will be sold at prevailing market prices, with Cantor earning a 3% commission
- Proceeds will be used for working capital and advancing bempikibart into future clinical trials for alopecia areata
- The company has a market cap of $104M and the public float is approximately $74.2M
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access